Zobrazeno 1 - 10 of 4 195 pro vyhledávání: '"Blume B"'
2
Akademický článek
Novel Methionine Aminopeptidase 2 Inhibitor M8891 Synergizes with VEGF Receptor Inhibitors to Inhibit Tumor Growth of Renal Cell Carcinoma Models.
Autor: Friese-Hamim M; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Ortiz Ruiz MJ; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Bogatyrova O; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Keil M; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Rohdich F; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Blume B; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Leuthner B; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Czauderna F; Research Unit Oncology, EMD Serono Research & Development Institute Inc., Billerica, Massachusetts., Hahn D; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Jabs J; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Jaehrling F; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Heinrich T; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Kellner R; Discovery Technologies, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Chan K; Donnelly Centre, University of Toronto, Toronto, Ontario, Canada., Tong AHY; Donnelly Centre, University of Toronto, Toronto, Ontario, Canada., Wienke D; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Moffat J; Donnelly Centre, University of Toronto, Toronto, Ontario, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.; Institute for Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada., Blaukat A; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany., Zenke FT; Research Unit Oncology, Merck Healthcare KGaA, the healthcare business of Merck KGaA, Darmstadt, Germany.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2024 Feb 01; Vol. 23 (2), pp. 159-173.
Zobrazit plný text záznamu
3
Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes (Nature Genetics, (2020), 52, 5, (473-481), 10.1038/s41588-020-0615-4)
Autor: Cortese A., Zhu Y., Rebelo A. P., Negri S., Courel S., Abreu L., Bacon C. J., Bai Y., Bis-Brewer D. M., Bugiardini E., Buglo E., Danzi M. C., Feely S. M. E., Athanasiou-Fragkouli A., Haridy N. A., Rodriguez A., Bacha A., Kosikowski A., Wood B., McCray B., Blume B., Siskind C., Sumner C., Calabrese D., Walk D., Vujovic D., Park E., Muntoni F., Donlevy G., Acsadi G., Day J., Burns J., Li J., Krajewski K., Eichinger K., Cornett K., Mullen K., Laura P. Q., Gutmann L., Barrett M., Saporta M., Skorupinska M., Grant N., Bray P., Seyedsadjadi R., Zuccarino R., Finkel R., Lewis R., Yum S., Hilbert S., Thomas S., Behrens-Spraggins S., Jones T., Lloyd T., Grider T., Estilow T., Fridman V., Isasi R., Khan A., Laura M., Magri S., Pipis M., Pisciotta C., Powell E., Rossor A. M., Saveri P., Sowden J. E., Tozza S., Vandrovcova J., Dallman J., Grignani E., Marchioni E., Scherer S. S., Tang B., Lin Z., Al-Ajmi A., Schule R., Synofzik M., Maisonobe T., Stojkovic T., Auer-Grumbach M., Abdelhamed M. A., Hamed S. A., Zhang R., Manganelli F., Santoro L., Taroni F., Pareyson D., Houlden H., Herrmann D. N., Reilly M. M., Shy M. E., Zhai R. G., Zuchner S.
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::fa2f2639bada99e106229ff5b044a7c0
http://hdl.handle.net/11588/808647
Zobrazit plný text záznamu
4
Periodical
Buchbesprechung: Handbuch der Bodenuntersuchung. Von H.-P. Blume, B. Deller, R. Leschber, A. Paetz, S. Schmidt und B.-M. Wilke
Autor: Fischer, Walter
Publikováno v: Journal of Plant Nutrition and Soil Science/Zeitschrift für Pflanzenernährung und Bodenkunde; December 2002, Vol. 165 Issue: 6 p746-747, 2p
Zobrazit plný text záznamu
5
Akademický článek
Lipidomic and Metallomic Alteration of Caenorhabditis elegans after Acute and Chronic Manganese, Iron, and Zinc Exposure with a Link to Neurodegenerative Disorders.
Autor: Blume B; Research Unit Analytical BioGeoChemistry, Helmholtz Zentrum München-German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany., Schwantes V; Institute for Inorganic and Analytical Chemistry, University of Münster, 48149 Münster, Germany., Witting M; Metabolomics and Proteomics, Helmholtz Zentrum München-German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany.; Chair of Analytical Food Chemistry, TUM School of Life Science, Technical University of Munich, 85354 Freising-Weihenstephan, Germany., Hayen H; Institute for Inorganic and Analytical Chemistry, University of Münster, 48149 Münster, Germany., Schmitt-Kopplin P; Research Unit Analytical BioGeoChemistry, Helmholtz Zentrum München-German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany.; Chair of Analytical Food Chemistry, TUM School of Life Science, Technical University of Munich, 85354 Freising-Weihenstephan, Germany., Helmer PO; Institute for Inorganic and Analytical Chemistry, University of Münster, 48149 Münster, Germany., Michalke B; Research Unit Analytical BioGeoChemistry, Helmholtz Zentrum München-German Research Center for Environmental Health (GmbH), 85764 Neuherberg, Germany.
Publikováno v: Journal of proteome research [J Proteome Res] 2023 Mar 03; Vol. 22 (3), pp. 837-850. Date of Electronic Publication: 2023 Jan 03.
Zobrazit plný text záznamu
6
Akademický článek
Reasons for dropout in the transition from hospital to municipality during exercise-based cardiac rehabilitation in a Danish cross-sectorial setting: a qualitative study.
Autor: Damlund ARS; Department of Occupational Therapy and Physiotherapy, Zealand University Hospital Roskilde, Roskilde, Sjaelland, Denmark arad@regionsjaelland.dk., Jørgensen LB; Department of Occupational Therapy and Physiotherapy, Zealand University Hospital Roskilde, Roskilde, Sjaelland, Denmark.; Department of Physiotherapy and Occupational Therapy, Næstved, Slagelse, Ringsted Hospital, Slagelse Hospital, Slagelse, Sjaelland, Denmark., Blume B; Department of Occupational Therapy and Physiotherapy, Zealand University Hospital Roskilde, Roskilde, Sjaelland, Denmark., Skou ST; Department of Physiotherapy and Occupational Therapy, Research Unit PROgrez, Næstved-Slagelse-Ringsted Hospitals, Slagelse, Denmark.; Department of Sports Science and Clinical Biomechanics, Research Unit for Musculoskeletal Function and Physiotherapy, University of Southern Denmark, Odense, Denmark., Tang LH; Department of Physiotherapy and Occupational Therapy, Slagelse Hospital, Slagelse, Sjaelland, Denmark.; The Department of Regional Health Research, University of Southern Denmark, Odense, Syddanmark, Denmark., Møller T; The University Hospitals Centre for Health Research (UCSF), Department 9701, Copenhagen University Hospital, Copenhagen, Denmark.
Publikováno v: BMJ open [BMJ Open] 2022 Nov 29; Vol. 12 (11), pp. e064660. Date of Electronic Publication: 2022 Nov 29.
Zobrazit plný text záznamu
7
Akademický článek
Dropout during a 12-week transitional exercise-based cardiac rehabilitation programme: a mixed-methods prospective cohort study.
Autor: Sommer CG; Department of Occupational Therapy and Physiotherapy, Zealand University Hospital, Sygehusvej 10, 4000 Roskilde, Denmark., Jørgensen LB; Department of Occupational Therapy and Physiotherapy, Zealand University Hospital, Sygehusvej 10, 4000 Roskilde, Denmark.; Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Region Zealand, Fælledvej 2c, DK-4200 Slagelse, Denmark.; Research Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark., Blume B; Department of Occupational Therapy and Physiotherapy, Zealand University Hospital, Sygehusvej 10, 4000 Roskilde, Denmark., Møller T; The University Hospitals Centre for Health Research (UCSF), Copenhagen University Hospital, Rigshospitalet, Department 9701, Ryesgade 27, DK-2200 Copenhagen, Denmark., Skou ST; Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Region Zealand, Fælledvej 2c, DK-4200 Slagelse, Denmark.; Research Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark., Harrison A; Department of Health Sciences, University of York, Seebohm Rowntree Building Heslington York, YO10 5DD England, UK., Tang LH; Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Region Zealand, Fælledvej 2c, DK-4200 Slagelse, Denmark.; Department of Regional Health Research, University of Southern Denmark, J.B. Winsløws Vej 19, 3 5000 Odense C, Denmark.
Publikováno v: European journal of cardiovascular nursing [Eur J Cardiovasc Nurs] 2022 Aug 29; Vol. 21 (6), pp. 578-586.
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies.
Autor: Zimmermann A; Translational Innovation Platform Oncology and Immuno-Oncology, The Healthcare Business of Merck KGaA, Darmstadt, Germany., Zenke FT; Translational Innovation Platform Oncology and Immuno-Oncology, The Healthcare Business of Merck KGaA, Darmstadt, Germany., Chiu LY; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, Massachusetts., Dahmen H; Translational Innovation Platform Oncology and Immuno-Oncology, The Healthcare Business of Merck KGaA, Darmstadt, Germany., Pehl U; Discovery and Development Technologies, Cellular Pharmacology, The Healthcare Business of Merck KGaA, Darmstadt, Germany., Fuchss T; Discovery and Development Technologies, Global Medicinal Chemistry, The Healthcare Business of Merck KGaA, Darmstadt, Germany., Grombacher T; Translational Medicine, The Healthcare Business of Merck KGaA, Darmstadt, Germany., Blume B; Discovery and Development Technologies, Cellular Pharmacology, The Healthcare Business of Merck KGaA, Darmstadt, Germany., Vassilev LT; Translational Innovation Platform Oncology and Immuno-Oncology, EMD Serono, Billerica, Massachusetts., Blaukat A; Translational Innovation Platform Oncology and Immuno-Oncology, The Healthcare Business of Merck KGaA, Darmstadt, Germany.
Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Jun 01; Vol. 21 (6), pp. 859-870.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje